Treatment of HER-2/neu overexpressing breast cancer xenograft models with trastuzumab (Herceptin) and gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fr (Q40568575)
Jump to navigation
Jump to search
scientific article published on April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of HER-2/neu overexpressing breast cancer xenograft models with trastuzumab (Herceptin) and gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fr |
scientific article published on April 2004 |
Statements
1 reference
Treatment of HER-2/neu overexpressing breast cancer xenograft models with trastuzumab (Herceptin) and gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fr (English)
1 reference
Corinna Warburton
1 reference
Wieslawa H Dragowska
1 reference
Karen Gelmon
1 reference
Stephen Chia
1 reference
Hong Yan
1 reference
Dana Masin
1 reference
Tetyana Denyssevych
1 reference
Anne E Wallis
1 reference
Marcel B Bally
1 reference
1 April 2004
1 reference
1 reference
2512-2524
1 reference
Identifiers
1 reference